BHCC(SH:600800)2025-04-28 09:05Financial Performance - The company's operating revenue for Q1 2025 was ¥838,713,853.99, a decrease of 35.77% compared to ¥1,305,748,830.21 in the same period last year[4] - The net profit attributable to shareholders was -¥168,903,048.09, showing a slight improvement from -¥177,380,295.57 year-on-year[4] - The basic earnings per share for the period was -¥0.15, compared to -¥0.16 in the previous year[5] - Total operating revenue for Q1 2025 was approximately ¥838.71 million, a decrease of 35.8% compared to ¥1,305.75 million in Q1 2024[17] - Net loss for Q1 2025 was approximately ¥168.90 million, compared to a net loss of ¥177.38 million in Q1 2024, showing an improvement of 4.2%[18] - The company’s total comprehensive loss for Q1 2025 was approximately ¥168.88 million, compared to a loss of ¥177.45 million in Q1 2024, indicating a reduction in losses[18] Assets and Liabilities - The total assets at the end of the reporting period were ¥4,101,084,206.27, reflecting a 5.05% increase from ¥3,903,796,811.22 at the end of the previous year[5] - As of March 31, 2025, the total assets of Tianjin Bohai Chemical Co., Ltd. amounted to CNY 4,101,084,206.27, an increase from CNY 3,903,796,811.22 as of December 31, 2024, reflecting a growth of approximately 5.06%[12] - The company's current assets totaled CNY 1,526,196,109.89, up from CNY 1,365,027,615.05, indicating an increase of about 11.79%[12] - The total liabilities increased to CNY 2,503,342,975.47 from CNY 2,139,838,706.70, representing a rise of approximately 16.94%[14] - The short-term borrowings rose significantly to CNY 1,059,674,650.13 from CNY 716,940,750.00, marking an increase of about 47.73%[14] - The total equity attributable to shareholders decreased to CNY 1,596,623,324.87 from CNY 1,762,841,617.45, a decline of about 9.42%[14] Cash Flow - The net cash flow from operating activities was -¥328,699,828.82, significantly worse than -¥2,338,178.04 in the same period last year[4] - Cash flow from operating activities for Q1 2025 was negative at approximately ¥328.70 million, compared to negative ¥2.34 million in Q1 2024[21] - The company generated cash inflows from operating activities totaling approximately ¥1,137.76 million in Q1 2025, down from ¥1,353.33 million in Q1 2024[21] - Cash and cash equivalents at the end of Q1 2025 were approximately ¥682.04 million, down from ¥1,028.50 million at the end of Q1 2024[23] - The company's cash and cash equivalents stood at CNY 764,946,155.10, slightly down from CNY 777,573,618.63[12] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 56,994[9] - Tianjin Bohai Chemical Group Co., Ltd. remains the largest shareholder, holding 28.41% of the shares[9] Operational Challenges - The company experienced a longer maintenance shutdown period, leading to reduced production and sales, which contributed to the decline in revenue[7] - The company reported non-recurring losses totaling -¥867,914.16 for the period[7] Inventory and Expenses - The company's inventory surged to CNY 575,947,777.25, compared to CNY 302,504,460.08, reflecting an increase of approximately 90.38%[12] - Research and development expenses for Q1 2025 were approximately ¥40.49 million, a decrease of 29.4% from ¥57.33 million in Q1 2024[17] - The company incurred financial expenses of approximately ¥12.18 million in Q1 2025, an increase from ¥9.88 million in Q1 2024[17] - The company reported a significant increase in prepayments, which rose to CNY 81,386,716.42 from CNY 35,524,817.38, indicating a growth of about 129.00%[12] - The long-term borrowings increased to CNY 300,504,000.00 from CNY 34,900,000.00, reflecting a substantial rise of approximately 760.00%[14]